Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bionano Genomics

3.03
-0.3300-9.82%
Post-market: 3.030.00000.00%19:58 EDT
Volume:90.96K
Turnover:281.83K
Market Cap:9.11M
PE:-0.02
High:3.24
Open:3.24
Low:2.99
Close:3.36
Loading ...

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results

Simply Wall St.
·
03 Apr

Stock Track | Bionano Genomics Plunges 8% in Pre-market Following Mixed 2024 Results and Analyst Caution

Stock Track
·
03 Apr

Stock Track | Bionano Genomics Plunges 8% After-Hours on Mixed 2024 Results and Maintained Hold Rating

Stock Track
·
03 Apr

Bionano Genomics Is Maintained at Sector Perform by Scotiabank

Dow Jones
·
03 Apr

Stock Track | Bionano Genomics Soars 5% as Scotiabank Quadruples Price Target, Revenue Beats Expectations

Stock Track
·
02 Apr

Scotiabank Sticks to Its Hold Rating for BioNano Genomics (BNGO)

TIPRANKS
·
02 Apr

Bionano Genomics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
02 Apr

U.S. RESEARCH ROUNDUP- Beacon Roofing Supply, Carvana, Reinsurance Group of America

Reuters
·
02 Apr

Stock Track | Bionano Genomics (BNGO) Soars 8.24% Following Positive Q4 2024 Earnings Report

Stock Track
·
01 Apr

Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ...

GuruFocus.com
·
01 Apr

Bionano Genomics Q4 2024 Earnings Call Summary and Q&A Highlights: Strategic Focus on Routine Users and Optical Genome Mapping

Live Track
·
01 Apr

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
01 Apr

Bionano Genomics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Stock Track | Bionano Genomics Soars 7.53% After-Hours on Strong Q4 Results and Positive 2025 Outlook

Stock Track
·
01 Apr

Bionano Genomics Inc - Expects FY 2025 Revenue Between $29 Million and $32 Million

THOMSON REUTERS
·
01 Apr

Bionano Genomics Outlook Q1 Revenue $6.2 Mln to $6.3 Mln

THOMSON REUTERS
·
01 Apr

Press Release: Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Dow Jones
·
01 Apr

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview

Reuters
·
29 Mar

Stock Track | Bionano Genomics Soars 5.23% Pre-Market on Breakthrough Neural Tube Defects Study Using OGM Technology

Stock Track
·
24 Mar

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

GlobeNewswire
·
24 Mar